Cargando…

c-Abl Inhibitors Enable Insights into the Pathophysiology and Neuroprotection in Parkinson’s Disease

Parkinson’s disease (PD) is a progressive neurodegenerative disorder causing movement disabilities and several non-motor symptoms in afflicted patients. Recent studies in animal models of PD and analyses of brain specimen from PD patients revealed an increase in the level and activity of the non-rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindholm, Dan, Pham, Dan D., Cascone, Annunziata, Eriksson, Ove, Wennerberg, Krister, Saarma, Mart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080529/ https://www.ncbi.nlm.nih.gov/pubmed/27833551 http://dx.doi.org/10.3389/fnagi.2016.00254

Ejemplares similares

Unveiling the Function of the Mitochondrial Filament-Forming Protein LACTB in Lipid Metabolism and Cancer
por: Cascone, Annunziata, et al.
Publicado: (2022)

Destabilization of the Outer and Inner Mitochondrial Membranes by Core and Linker Histones
por: Cascone, Annunziata, et al.
Publicado: (2012)

Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration – A Mass Spectrometry Imaging Study of the Perfused Rat Liver
por: Calza, Giulio, et al.
Publicado: (2018)

Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease
por: Lindholm, Dan, et al.
Publicado: (2017)

The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson’s disease mouse model
por: Lee, Saebom, et al.
Publicado: (2018)

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism
por: Lindholm, Päivi, et al.
Publicado: (2021)

Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson’s Disease
por: Galli, Emilia, et al.
Publicado: (2019)

CDNF Protein Therapy in Parkinson’s Disease
por: Huttunen, Henri J., et al.
Publicado: (2019)

Neuroprotective Efficacy of a New Brain-Penetrating C-Abl Inhibitor in a Murine Parkinson’s Disease Model
por: Imam, Syed Z., et al.
Publicado: (2013)

Endoplasmic Reticulum Stress Regulators: New Drug Targets for Parkinson’s Disease
por: Kovaleva, Vera, et al.
Publicado: (2021)

Neurotrophic Factors in Parkinson’s Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain
por: Bondarenko, Olesja, et al.
Publicado: (2021)

Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies
por: Chmielarz, Piotr, et al.
Publicado: (2020)

Commentary: LACTB is a tumour suppressor that modulates lipid metabolism and cell state
por: Eriksson, Ove, et al.
Publicado: (2017)

CDNF and MANF regulate ER stress in a tissue-specific manner
por: Pakarinen, Emmi, et al.
Publicado: (2022)

GDNF-deprived sympathetic neurons die via a novel nonmitochondrial pathway
por: Yu, Li-Ying, et al.
Publicado: (2003)

EnABLing microprocessor for apoptosis
por: Tu, Chi-Chiang, et al.
Publicado: (2015)

Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson’s Disease
por: Garea-Rodríguez, Enrique, et al.
Publicado: (2016)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
por: Penttinen, Anna-Maija, et al.
Publicado: (2018)

In vivo screening reveals interactions between Drosophila Manf and genes involved in the mitochondria and the ubiquinone synthesis pathway
por: Lindström, Riitta, et al.
Publicado: (2017)

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
por: Pietarinen, Paavo O., et al.
Publicado: (2017)

Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches
por: Frisardi, Vincenza, et al.
Publicado: (2016)

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Short-term Preoperative Dietary Restriction Is Neuroprotective in a Rat Focal Stroke Model
por: Varendi, Kärt, et al.
Publicado: (2014)

Exploring the Conserved Role of MANF in the Unfolded Protein Response in Drosophila melanogaster
por: Lindström, Riitta, et al.
Publicado: (2016)

Characterization of CDNF-Secreting ARPE-19 Cell Clones for Encapsulated Cell Therapy
por: Galli, Emilia, et al.
Publicado: (2019)

Genetics of vestibular disorders: pathophysiological insights
por: Frejo, Lidia, et al.
Publicado: (2016)

Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Is Highly Expressed in Mouse Tissues With Metabolic Function
por: Danilova, Tatiana, et al.
Publicado: (2019)

Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats
por: Renko, Juho-Matti, et al.
Publicado: (2021)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Caspase-2 and p75 neurotrophin receptor (p75NTR) are involved in the regulation of SREBP and lipid genes in hepatocyte cells
por: Pham, Dan Duc, et al.
Publicado: (2019)

Hiccups, Hypersalivation, Hallucinations in Parkinson’s Disease: New Insights, Mechanisms, Pathophysiology, and Management
por: Metta, Vinod, et al.
Publicado: (2023)

Success in the workplace: From the voice of (dis)abled to the voice of enabled
por: Marsay, Gloria
Publicado: (2014)

c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential
por: Brahmachari, Saurav, et al.
Publicado: (2017)

The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
por: Karuppagounder, Senthilkumar S., et al.
Publicado: (2014)

Increased circulating concentrations of mesencephalic astrocyte-derived neurotrophic factor in children with type 1 diabetes
por: Galli, Emilia, et al.
Publicado: (2016)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
por: Mian, Afsar Ali, et al.
Publicado: (2012)

Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration
por: Sidorova, Yulia A., et al.
Publicado: (2020)

Biological Markers for Pulpal Inflammation: A Systematic Review
por: Rechenberg, Dan-Krister, et al.
Publicado: (2016)

Tau in the Pathophysiology of Parkinson’s Disease
por: Pan, Lina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nb7dbaqkl62i15in4ms5qaqvkg